Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Environment International
|
February 6, 2017
Chemical alternatives assessment of different flame retardants - A case study including multi-walled carbon nanotubes as synergist
Karin Aschberger, Ivana Campia, Laia Quiros Pesudo, et al.
Applied in Vitro Toxicology
|
July 31, 2018
Creating a Structured AOP Knowledgebase via Ontology-Based Annotations
Cataia Ives, Ivana Campia, Rong-Lin Wang, et al.
Toxicology and Applied Pharmacology
|
August 4, 2009
Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells
Chiara Riganti, Ivana Campia, Manuela Polimeni, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 10, 2026
Corrigendum to 'A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells' [Journal of Controlled Release 149(2) (2011) 196-205]
Joanna Kopecka, Ivana Campia, Paolo Olivero, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 16, 2010
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
Joanna Kopecka, Ivana Campia, Paolo Olivero, et al.
Current Drug Metabolism
|
July 23, 2013
Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier
Martha Leonor Pinzón-Daza, Ivana Campia, Joanna Kopecka, et al.
Current Drug Metabolism
|
October 16, 2008
Classical inhibitors of NOX NAD(P)H oxidases are not specific
Elisabetta Aldieri, Chiara Riganti, Manuela Polimeni, et al.
Oncotarget
|
December 30, 2014
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
Iris Chiara Salaroglio, Ivana Campia, Joanna Kopecka, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 16, 2013
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition
Joanna Kopecka, Giuseppina Salzano, Ivana Campia, et al.
Oncotarget
|
February 18, 2015
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
Joanna Kopecka, Ivana Campia, Andrea Jacobs, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Environment International
|
February 6, 2017
Chemical alternatives assessment of different flame retardants - A case study including multi-walled carbon nanotubes as synergist
Karin Aschberger, Ivana Campia, Laia Quiros Pesudo, et al.
Applied in Vitro Toxicology
|
July 31, 2018
Creating a Structured AOP Knowledgebase via Ontology-Based Annotations
Cataia Ives, Ivana Campia, Rong-Lin Wang, et al.
Toxicology and Applied Pharmacology
|
August 4, 2009
Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells
Chiara Riganti, Ivana Campia, Manuela Polimeni, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 10, 2026
Corrigendum to 'A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells' [Journal of Controlled Release 149(2) (2011) 196-205]
Joanna Kopecka, Ivana Campia, Paolo Olivero, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 16, 2010
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
Joanna Kopecka, Ivana Campia, Paolo Olivero, et al.
Current Drug Metabolism
|
July 23, 2013
Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier
Martha Leonor Pinzón-Daza, Ivana Campia, Joanna Kopecka, et al.
Current Drug Metabolism
|
October 16, 2008
Classical inhibitors of NOX NAD(P)H oxidases are not specific
Elisabetta Aldieri, Chiara Riganti, Manuela Polimeni, et al.
Oncotarget
|
December 30, 2014
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
Iris Chiara Salaroglio, Ivana Campia, Joanna Kopecka, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 16, 2013
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition
Joanna Kopecka, Giuseppina Salzano, Ivana Campia, et al.
Oncotarget
|
February 18, 2015
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
Joanna Kopecka, Ivana Campia, Andrea Jacobs, et al.
Page
of 3